Metabolomic Profiling of the Synergistic Effects of Melittin in Combination with Cisplatin on Ovarian Cancer Cells

Melittin, the main peptide present in bee venom, has been proposed as having potential for anticancer therapy; the addition of melittin to cisplatin, a first line treatment for ovarian cancer, may increase the therapeutic response in cancer treatment via synergy, resulting in improved tolerability,...

Descripción completa

Detalles Bibliográficos
Autores principales: Alonezi, Sanad, Tusiimire, Jonans, Wallace, Jennifer, Dufton, Mark J., Parkinson, John A., Young, Louise C., Clements, Carol J., Park, Jin-Kyu, Jeon, Jong-Woon, Ferro, Valerie A., Watson, David G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487985/
https://www.ncbi.nlm.nih.gov/pubmed/28420117
http://dx.doi.org/10.3390/metabo7020014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487985/
https://www.ncbi.nlm.nih.gov/pubmed/28420117
http://dx.doi.org/10.3390/metabo7020014

Ejemplares similares